Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy.

Kazuhiko Yoshimatsu; Hiroyuki Kato; Keiichiro Ishibashi; Masahiko Hashimoto; Arihiro Umehara; Hajime Yokomizo; Kiyohito Yoshida; Takashi Fujimoto; Kiyo Iwasaki; Kenji Ogawa

doi:10.1007/s00280-003-0686-9

Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy.

Identifier:nobleid.org/w1/20260515/BE8FF281

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BE8FF281.svg?ark=w1%2F20260515%2FBE8FF281)](https://nobleid.org/work/w1/20260515/BE8FF281)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy.

Identifier:nobleid.org/w1/20260515/BE8FF281

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BE8FF281.svg?ark=w1%2F20260515%2FBE8FF281)](https://nobleid.org/work/w1/20260515/BE8FF281)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work